Nooka, Ajay K. http://orcid.org/0000-0003-4165-6869
Kaufman, Jonathan L. http://orcid.org/0000-0002-5687-6429
Rodriguez, Cesar
Jakubowiak, Andrzej http://orcid.org/0000-0002-2597-6822
Efebera, Yvonne
Reeves, Brandi http://orcid.org/0000-0002-2106-3698
Wildes, Tanya
Holstein, Sarah A. http://orcid.org/0000-0002-9342-5635
Anderson, Larry D. Jr http://orcid.org/0000-0002-6531-9595
Badros, Ashraf
Shune, Leyla
Chari, Ajai
Pei, Huiling
Cortoos, Annelore
Patel, Sharmila
Bartlett, J. Blake
Vermeulen, Jessica
Lin, Thomas S.
Richardson, Paul G. http://orcid.org/0000-0002-7426-8865
Voorhees, Peter
Funding for this research was provided by:
Janssen Oncology
Article History
Received: 2 December 2021
Revised: 18 March 2022
Accepted: 21 March 2022
First Online: 13 April 2022
Competing interests
: AKN served as a consultant for, received honoraria from, and received research funding from Janssen, Amgen, Takeda, Sanofi, Karyopharm Therapeutics, Bristol Myers Squibb, Oncopeptides, Adaptive, and Spectrum. JLK has served as a consultant for, received honoraria from, or received research funding from AbbVie, Amgen, Bristol Myers Squibb, Fortis Therapeutics, Heidelberg Pharma, Janssen, Novartis, Roche/Genentech, Sutro Biopharma, Takeda, and Tecnopharma; and has served as a member on the board of directors or advisory committees for Incyte and TG Therapeutics. CR has served as an advisor or speaker for Amgen, Bristol Myers Squibb, Janssen, Karyopharm, and Takeda. AJ held membership on an entity’s board of directors or served on advisory committees for Sanofi, Karyopharm, Janssen, GlaxoSmithKline, Amgen, AbbVie, Bristol Myers Squibb, Gracell, and Celgene. YE has received honoraria from Janssen, GlaxoSmithKline, Takeda, Oncopeptide, Alnylam, and Sanofi; served on a speakers bureau and/or as an advisor for Oncopeptide, Sanofi, Janssen, Takeda, Alnylam, and GlaxoSmithKline; and received research funding from Bristol Myers Squibb/Celgene. BR has received honoraria from Takeda and Incyte; served on a speakers bureau for Bristol Myers Squibb; and provided consultancy for and received honoraria from Pharma Essentia. TW has served as a consultant for Janssen, Carevive, Sanofi, and Seattle Genetics. SAH held membership on an entity’s board of directors or served on an advisory committee for Oncopeptides, Celgene, and Takeda; received honoraria from Celgene, Genentech, GlaxoSmithKline, Janssen, Secura Bio, Sorrento, and Takeda; and received research funding from Oncopeptides. LDA has served as a consultant for, received research funding or honoraria from, held membership on an entity’s board of directors or served on advisory committees for Amgen, Bristol Myers Squibb, Celgene, Janssen, GlaxoSmithKline, Janssen, Karyopharm, AbbVie, Prothena, and Oncopeptides. AB has received research funding from Bristol Myers Squibb and GlaxoSmithKline. LS has nothing to disclose. ACh held membership on an entity’s board of directors, or participated on advisory committees for AbbVie, Amgen, Bristol Myers Squibb/Celgene, Genentech, GlaxoSmithKline, Janssen, Karyopharm, Oncopeptides, Sanofi, Seattle Genetics, Secura Bio, Antengene, and Shattuck Labs; received research funding from Amgen, Bristol Myers Squibb/Celgene, Janssen, Seattle Genetics, Pharmacyclics, and Takeda/Millennium; and acted as a consultant for Amgen, AbbVie, Antengene, Bristol Myers Squibb/Celgene, Genentech, GlaxoSmithKline, Janssen, Karyopharm, Novartis, Sanofi, Secura Bio, Shattuck Labs, and Takeda/Millennium. HP, ACo, BB, and JV are current employees and stock shareholders of Janssen. SP is a current employee of Janssen. TSL is a current employee and stock shareholder of Janssen and holds stock in GlaxoSmithKline. PGR has received research funding from Celgene/Bristol Myers Squibb, Karyopharm, Oncopeptides, and Takeda; and has served on advisory committees for AstraZeneca, Celgene/Bristol Myers Squibb, GlaxoSmithKline, Janssen, Karyopharm, Oncopeptides, Protocol Intelligence, Regeneron, Sanofi, and Secura Bio. PV has served as a consultant for, received honoraria from, or served as an advisory board member for AbbVie, Amgen, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Karyopharm, Novartis, Oncopeptides, Pfizer, Sanofi, and Secura Bio.